Junchen Gu
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
-
- bioluminescence and chemiluminescence research 1
- RNA modifications and cancer 1
- Nicotinic Acetylcholine Receptors Study 1
- Co-authors
- Ana Oaknin (2 shared papers)José M. López-Picazo (2 shared papers)R. Wendel Naumann (2 shared papers)Kathleen N. Moore (2 shared papers)Valentina Boni (2 shared papers)Tim Meyer (2 shared papers)Suzanne L. Topalian (2 shared papers)Emiliano Calvo (1 shared paper)
- Journals
- HemaSphere (1 paper)BMC Genomics (1 paper)Molecular Oncology (1 paper)Journal of Clinical Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Junchen Gu
6 papers receiving 431 citations
Junchen Gu's Hit Papers
Peers
Comparison fields: 5 of 52
- Obstetrics and Gynecology 158
- Oncology 260
- Reproductive Medicine 56
- Immunology 108
- Epidemiology 109
Countries citing papers authored by Junchen Gu
This map shows the geographic impact of Junchen Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junchen Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junchen Gu more than expected).
Fields of papers citing papers by Junchen Gu
This network shows the impact of papers produced by Junchen Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junchen Gu. The network helps show where Junchen Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junchen Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial Hit paper breakdown → | 2019 | 299 |
| 2 | 2019 | 59 | |
| 3 | 2016 | 31 | |
| 4 | 2017 | 20 | |
| 5 | 2022 | 18 | |
| 6 | 2021 | 10 | |
| 7 | 2022 | 0 |
About Junchen Gu
Junchen Gu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 7 papers that have together received 437 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Insect and Pesticide Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Endometrial and Cervical Cancer Treatments (1 paper), bioluminescence and chemiluminescence research (1 paper), RNA modifications and cancer (1 paper) and Nicotinic Acetylcholine Receptors Study (1 paper). The work is most often cited by research in Obstetrics and Gynecology (158 citations), Oncology (260 citations), Reproductive Medicine (56 citations), Immunology (108 citations) and Epidemiology (109 citations). Junchen Gu has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ana Oaknin, José M. López-Picazo, R. Wendel Naumann, Kathleen N. Moore, Valentina Boni, Tim Meyer, Suzanne L. Topalian, Emiliano Calvo, Antoine Hollebecque and Ricardo Zwirtes. Their work appears in journals such as HemaSphere, BMC Genomics, Molecular Oncology, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.